vTv Therapeutics Inc. (VTVT)

Every figure this model derived for VTVT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 86,643,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 87,589,000 AssetsCurrent 2026-06-30
current liabilities 7,017,000 LiabilitiesCurrent 2026-06-30
equity 78,632,000 StockholdersEquity 2026-06-30
interest expense 6,000 InterestPaidNet 2025-12-31
ocf -16,762,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 36,839,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 5,147,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up VTVT on one particular measure came for.

RatioValue
cash operating margin-11.12
current ratio12.48
current ratio reported12.48
deferred revenue growth-100.0
fcf margin-45.5
interest cover-1541.83
operating margin-25.11
owner earnings margin-59.47
revenue growth216600.0
revenue growth per share216600.0
rule of 40216574.89
sbc pct revenue13.97

What to be careful about

What this model itself distrusts about VTVT's figures. Written by the derivation as it ran, not added afterwards.